AKBA
Akebia Ther
NASDAQ: AKBA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.36
-4.23% today
Updated 2026-04-29
Market cap
$364.82M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$1 – $4
Volume
2.7M
Akebia Ther (AKBA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $700233.00 | $0.00 | $1.53M | $177.98M | $207.74M | $335.00M | $295.31M | $213.58M | $292.48M | $194.62M | $160.18M | $236.20M |
| Revenue growth (YoY) | — | — | — | -100.0% | — | +11495.0% | +16.7% | +61.3% | -11.8% | -27.7% | +36.9% | -33.5% | -17.7% | +47.5% |
| Cost of revenue | — | — | $23.26M | $96000.00 | $115.78M | $617000.00 | $7.68M | $145.34M | $295.91M | $153.39M | $22.50M | $74.15M | $63.18M | $39.46M |
| Gross profit | — | — | $-23.26M | $-96000.00 | $-114.25M | $177.37M | $200.06M | $189.66M | $-601000.00 | $60.18M | $269.99M | $120.47M | $97.00M | $196.73M |
| Gross margin | — | — | -3322.2% | — | -7443.0% | 99.7% | 96.3% | 56.6% | -0.2% | 28.2% | 92.3% | 61.9% | 60.6% | 83.3% |
| R&D | $5.63M | $10.78M | $25.40M | $43.02M | $115.78M | $230.89M | $291.07M | $322.97M | $218.49M | $147.85M | $165.99M | $63.08M | $37.65M | $62.36M |
| SG&A | $2.89M | $5.15M | $12.54M | $18.50M | $22.21M | $27.01M | $87.13M | $152.98M | $157.36M | $177.65M | $131.90M | $3.24M | $101.94M | $107.48M |
| Operating income | $-8.52M | $-15.93M | $-37.94M | $-61.51M | $-136.46M | $-79.92M | $-178.14M | $-286.29M | $-376.44M | $-265.32M | $-80.78M | $-46.26M | $-50.47M | $23.50M |
| Operating margin | — | — | -5418.2% | — | -8889.9% | -44.9% | -85.8% | -85.5% | -127.5% | -124.2% | -27.6% | -23.8% | -31.5% | 9.9% |
| EBITDA | $-8.52M | $-12.46M | $-37.89M | $-61.42M | $-136.16M | $-76.06M | $-175.72M | $-247.64M | $-342.85M | $-227.35M | $3.06M | $-8.27M | $-13.72M | $21.73M |
| EBITDA margin | — | — | -5411.2% | — | -8870.6% | -42.7% | -84.6% | -73.9% | -116.1% | -106.4% | 1.0% | -4.2% | -8.6% | 9.2% |
| EBIT | $-8.52M | $-12.46M | $-37.94M | $-61.51M | $-136.46M | $-76.67M | $-178.14M | $-286.29M | $-376.44M | $-265.32M | $-34.64M | $-45.89M | $-51.23M | $20.46M |
| Interest expense | $1.64M | $703569.00 | $206000.00 | $510000.00 | $901000.00 | $2.80M | $6.15M | $38.64M | $8.87M | $19.94M | $15.69M | $6.03M | $18.18M | $24.18M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.20M | $-13.17M | $-37.03M | $-60.72M | $-135.75M | $-76.91M | $-171.90M | $-279.66M | $-349.87M | $-244.87M | $-94.23M | $-51.92M | $-69.41M | $-5.34M |
| Net income growth (YoY) | — | -60.7% | -181.3% | -63.9% | -123.6% | +43.3% | -123.5% | -62.7% | -25.1% | +30.0% | +61.5% | +44.9% | -33.7% | +92.3% |
| Profit margin | — | — | -5288.8% | — | -8843.5% | -43.2% | -82.7% | -83.5% | -118.5% | -114.7% | -32.2% | -26.7% | -43.3% | -2.3% |